SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-030874
Filing Date
2018-12-13
Accepted
2018-12-13 10:24:16
Documents
3
Period of Report
2018-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 5.02 atrs-8k_20181212.htm 8-K 35394
2 EX-99.1 PRESS RELEASE atrs-ex991_7.htm EX-99.1 13656
3 GRAPHIC gau35j02hofp000001.jpg GRAPHIC 3258
  Complete submission text file 0001564590-18-030874.txt   55226
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 181232383
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10